Synopsis
The primary objective of the study is to evaluate the effectiveness of DL-PDT when assisted by SmartPDT in the clearance of AK in clinical practice. Secondary objectives of the study include evaluating the satisfaction of patients and clinical staff in SmartPDT usability, evaluating the safety of SmartPDT use for DL-PDT and evaluating the incidence of relapses at 6 and 12 months after a DL-PDT session.
Authors
Y. Gilaberte, University Hospital Miguel Servet, Zaragoza, Spain
T. Gracia-Cazaña, University Hospital Miguel Servet, Zaragoza, Spain
O. Yélamos, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
A. Navarro Bielsa, University Hospital Miguel Servet, Zaragoza, Spain
M. Almenara Blasco, University Hospital Miguel Servet, Zaragoza, Spain
R. C. Temple, SiHealth Ltd, Harwell Campus, Oxfordshire, UK
M. Morelli, SiHealth Ltd, Harwell Campus, Oxfordshire, UK
